Zoetis Inc. (NYSE:ZTS) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition
On February14, 2019, Zoetis Inc. (the Company) issued a press release announcing its financial results for the fourth quarter and full year 2018 and providing its guidance for full year 2019. A copy of the Company’s press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Item 2.02 and in the attached Exhibit 99.1 is being furnished to the Securities and Exchange Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits
|
Exhibit No. |
Description |
|
Press Release of Zoetis Inc. dated February14, 2019, reporting Zoetis’ financial results for the fourth |
|
|
quarter and full year 2018 and providing its guidance for full year 2019. |
Zoetis Inc. Exhibit
EX-99.1 2 exhibit9912-31x18q4.htm EXHIBIT 99.1 Exhibit EXHIBIT 99.1Zoetis Reports Fourth Quarter and Full Year 2018 Results•For Fourth Quarter 2018,…
To view the full exhibit click here
About Zoetis Inc. (NYSE:ZTS)
Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a diversified business, marketing products across over eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock), and dogs, cats and horses (collectively, companion animals), and within over five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals. It operates through two segments: the United States and International. Within each of these segments, it offers a diversified product portfolio for both livestock and companion animal customers. In addition, its Client Supply Services (CSS) organization provides contract manufacturing services to third parties. It also offers other product categories, such as nutritionals and agribusiness.
